2m 2m 2m 2m 2m 2m 2m
Merck (MRK)
NYSE
$118.96+$3.47 (+3.01%)
Price as of Jun 23, 2026 3:13 PM EDT- $285.2BMarket Cap
- 48.88%1-Year Change
- Drug Manufacturers - GeneralIndustry
Merck (MRK)
$118.96+$3.47 (+3.01%)
MRK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $115.48 | ||
Change | +$1.61 (+1.41%) | ||
Open | $113.97 | ||
High | $115.63 | ||
Low | $113.00 | ||
Previous Close | $113.87 | ||
Volume | 10,593,865 | ||
30-Day Average Volume | 12,311,520 | ||
1-Week Change | 0.50% | ||
1-Month Change | -4.98% | ||
1-Year Change | 48.88% | ||
3-Year Change | 11.38% | ||
5-Year Change | 77.15% | ||
Fundamentals | |||
Shares Outstanding | 2.5B | ||
Total Assets | $128.7B | ||
Market Cap | $285.2B | ||
Enterprise Value | $329.0B | ||
Period: QTR TTM FY | |||
Revenue | $16.3B | ||
Net Income | -$4.2B | ||
Free Cash Flow | $2.9B | ||
EBIT | -$3.5B | ||
EBITDA | -$3.0B | ||
Net Working Capital | $8.1B | ||
EPS | -$1.72 | ||
Enterprise Value/EBITDA | -112 | ||
Enterprise Value/Revenue | 20 | ||
P/B | 6 | ||
P/E | -67 | ||
PEG | 0 | ||
Price/Free Cash Flow | 97 | ||
Price/Operating Cash Flow | 73 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.94% | ||
Trailing Annual Dividend Yield | 2.91% | ||
Ex-Dividend Date | 06/15/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield